Clinical experience with a mobile ocular perfusion pump
- PMID: 1180750
- DOI: 10.1001/archopht.1975.01010020815015
Clinical experience with a mobile ocular perfusion pump
Abstract
The continuous delivery in fluids to the ocular surfaces of 12 patients, for a collective total of 1,500 days, was achieved by means of a mobile perfusion pump. One patient used this device intermittently for a total of 21/2 years. Severe dry-eye symptoms were ameliorated in each patient by the constant perfusion. In various situations, the following perfusion fluids have been tried: commercial balanced salt solution, commercial artificial tear solutions, acetylcysteine, and autologous and homologous serum and plasma. In spite of disadvantages related to its size and weight, the pump seems to be of considerable value, especially following severe chemical burns and after keratoplasty or reconstruction of the lids and fornices in the severely dry eye.
Similar articles
-
A method for delivery of ocular medications.Ophthalmology. 1979 Jun;86(6):1202. doi: 10.1016/s0161-6420(79)35412-4. Ophthalmology. 1979. PMID: 534101
-
Mobile infusion pumps for continuous delivery of fluid and therapeutic agents to the eye.Ann Ophthalmol. 1971 Feb;3(2):126-8. Ann Ophthalmol. 1971. PMID: 5164421 No abstract available.
-
Methods of ophthalmic fluid delivery.Int Ophthalmol Clin. 1980 Fall;20(3):93-101. doi: 10.1097/00004397-198002030-00010. Int Ophthalmol Clin. 1980. PMID: 6998904 Review. No abstract available.
-
[Magnetotherapy in ophthalmology].Vestn Oftalmol. 1980 Sep-Oct;(5):63-5. Vestn Oftalmol. 1980. PMID: 7423737 Russian. No abstract available.
-
[Red eye in children].Rev Prat. 2008 Feb 29;58(4):353-7. Rev Prat. 2008. PMID: 18506971 Review. French.
Cited by
-
Autologous Platelet and Extracellular Vesicle-Rich Plasma as Therapeutic Fluid: A Review.Int J Mol Sci. 2023 Feb 8;24(4):3420. doi: 10.3390/ijms24043420. Int J Mol Sci. 2023. PMID: 36834843 Free PMC article. Review.
-
Immunomodulation on the ocular surface: a review.Cent Eur J Immunol. 2016;41(2):195-208. doi: 10.5114/ceji.2016.60995. Epub 2016 Jul 15. Cent Eur J Immunol. 2016. PMID: 27536206 Free PMC article. Review.
-
Evaluation of the efficacy of 50% autologous serum eye drops in different ocular surface pathologies.Biomed Res Int. 2014;2014:826970. doi: 10.1155/2014/826970. Epub 2014 Jul 22. Biomed Res Int. 2014. PMID: 25136628 Free PMC article. Clinical Trial.
-
20% Autologous serum vs. 0.05% cyclosporine and preservative-free artificial tears in the treatment of Sjögren related dry eye.Arq Bras Oftalmol. 2022 Nov 4;87(3):e2022-0192. doi: 10.5935/0004-2749.2022-0192. Online ahead of print. Arq Bras Oftalmol. 2022. PMID: 36350915 Free PMC article.
-
The use of autologous serum for the treatment of ocular surface disease at a Swedish tertiary referral center.Int Med Case Rep J. 2016 Mar 2;9:47-54. doi: 10.2147/IMCRJ.S97297. eCollection 2016. Int Med Case Rep J. 2016. PMID: 27042143 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical